These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19280854)

  • 1. The significance of serotype replacement for pneumococcal disease and antibiotic resistance.
    Klugman KP
    Adv Exp Med Biol; 2009; 634():121-8. PubMed ID: 19280854
    [No Abstract]   [Full Text] [Related]  

  • 2. The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation.
    Black S
    Pediatr Infect Dis J; 2010 Apr; 29(4):301-3. PubMed ID: 19935444
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.
    Esposito S; Principi N;
    Future Microbiol; 2015; 10(10):1599-607. PubMed ID: 26439470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotype 19A Bacteremic Pneumococcal Pneumonia After 4 Doses of 13-Valent Conjugate Vaccine: A Review of Pneumococcal Conjugate Vaccine Effectiveness.
    Iroh Tam PY; Hanisch BR; Forward B
    Clin Pediatr (Phila); 2015 Jun; 54(6):591-3. PubMed ID: 25500500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal conjugate vaccines: epidemiology guides clinical use.
    Heininger U
    Klin Padiatr; 2011 Mar; 223(2):59-60. PubMed ID: 21432762
    [No Abstract]   [Full Text] [Related]  

  • 6. Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
    van Werkhoven CH
    Hum Vaccin Immunother; 2017 May; 13(5):1177-1181. PubMed ID: 27937061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global epidemiology of pneumococcal disease--new prospects for vaccine control.
    Antao VC; Hausdorff WP
    Adv Exp Med Biol; 2009; 634():19-29. PubMed ID: 19280845
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of immunization with pneumococcal conjugated vaccines on Streptococcus pneumoniae resistance patterns in acute otitis media.
    Marom T; Avraham E; Cinamon U; Tamir SO
    J Microbiol Immunol Infect; 2017 Oct; 50(5):714-717. PubMed ID: 26507672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic Resistance of Potential Otopathogens Isolated From Nasopharyngeal Flora of Children With Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation.
    Rybak A; Levy C; Bonacorsi S; Béchet S; Vié le Sage F; Elbez A; Varon E; Cohen R
    Pediatr Infect Dis J; 2018 Mar; 37(3):e72-e78. PubMed ID: 29227464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.
    Joloba ML; Windau A; Bajaksouzian S; Appelbaum PC; Hausdorff WP; Jacobs MR
    Clin Infect Dis; 2001 Nov; 33(9):1489-94. PubMed ID: 11588694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal vaccines for infants and children--past, present, and future.
    Klein JO
    Curr Clin Top Infect Dis; 2002; 22():252-65. PubMed ID: 12520657
    [No Abstract]   [Full Text] [Related]  

  • 12. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].
    Rodgers GL; Arguedas A; Cohen R; Dagan R
    Vaccine; 2009 Sep; 27(40):5429-30. PubMed ID: 19643215
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.
    Rückinger S; van der Linden M; Siedler A; von Kries R
    Klin Padiatr; 2011 Mar; 223(2):61-4. PubMed ID: 21271500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015.
    Silva-Costa C; Brito MJ; Pinho MD; Friães A; Aguiar SI; Ramirez M; Melo-Cristino J; ;
    Emerg Infect Dis; 2018 Jul; 24(7):1307-1314. PubMed ID: 29912700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal vaccines: present and future.
    Peters TR; Edwards KM
    Pediatr Ann; 2002 Apr; 31(4):261-8. PubMed ID: 11966249
    [No Abstract]   [Full Text] [Related]  

  • 16. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR
    Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal conjugate vaccines probe studies: the solution points to the problem.
    Dagan R
    Adv Exp Med Biol; 2009; 634():69-77. PubMed ID: 19280850
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.
    Dagan R; Givon-Lavi N; Shkolnik L; Yagupsky P; Fraser D
    J Infect Dis; 2000 Apr; 181(4):1322-9. PubMed ID: 10753730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diversity of pneumococcal conjugate vaccine impact observed through their implementation.
    Dagan R
    Hum Vaccin Immunother; 2016; 12(2):266-7. PubMed ID: 26905677
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease.
    Principi N; Esposito S
    Expert Rev Vaccines; 2015; 14(10):1359-66. PubMed ID: 26289973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.